Ghana, Kenya and Malawi to pilot GSK malaria vaccine from 2018

Ghana, Kenya and Malawi will pilot the world's first malaria vaccine from 2018, offering it for babies and children in high-risk areas as part of real-life trials, the World Health Organization said on Monday.The injectable vaccine, called RTS,S or Mosquirix, was developed by British drugmaker GlaxoSmithKline to protect children from the most deadly form of malaria in Africa. In clinical trials it proved only partially effective, and it needs to be given in a four-dose schedule, but is the first regulator-approved vaccine against the mosquito-borne disease. Read more

Read 538 times
Share this article

About author

Heri Marco

Highly skilled in tracking details, communicating deadlines, and following up with internal and external stakeholders to ensure on time completion within budget. Ability and interest in learning and incorporating new technology. 

Business and Investment

  The Future of travel and tourism in the wake
Following the success of the inaugural Congress,
Main Grant Application Announcement : January
LAGOS, NIGERIA – Africa’s largest philanthropy
The Africa Region of the World Bank Group (WBG)
Top